New cancer drug LM-108 tested in humans for first time
Disease control
Completed
This was the first study in people to test a new drug called LM-108 for advanced solid tumors. It involved 78 adults whose cancer had progressed despite standard treatments. The main goals were to find a safe dose and see if the drug, given alone or with an immunotherapy, showed …
Phase: PHASE1, PHASE2 • Sponsor: LaNova Australia Pty Limited • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC